Why the study?
Antihypertensive medications can cause morbidity in older people with advanced frailty or limited life expectancy, creating uncertainty regarding when deprescribing is appropriate.
Should antihypertensive medications be deprescribed in older people with frailty, cognitive impairment, or limited life expectancy?
Should antihypertensive medications be deprescribed in older people with frailty, cognitive impairment, or limited life expectancy?
Deprescribing antihypertensive medications is a rational approach for select older patients with frailty, cognitive impairment, or limited life expectancy, though further research is required.
May support individualized deprescribing considerations in frail older adults; leaves open the need for randomized trials.
What happens when you stop? This is the third of a three-part series on antihypertensive medication use in older people. In the first, we reviewed the importance of better blood pressure (BP) control, even in older people with hypertension. In the second, we discussed the limitations of the evidence favoring intensive therapy for some older people. For older people with advanced frailty or those with a limited life expectancy, medications taken for BP can actually be a source of morbidity. Guidelines encourage clinical judgment and rational prescribing. Sometimes the best action is to stop prescribing. De-prescribing of medical therapy is now considered good practice for a range of medications for suitable patients; should this include antihypertensives? In part three of this three-part series, we will review some of the evidence available thus far, demonstrating de-intensification of antihypertensive medications is not a new idea. We will offer a guide to identifying the most suitable patients for de-prescribing: cognitive impairment, frailty, when circumstances change, or when BP is (too) well-controlled. This is an area of equipoise and needs more research. There is a path forward that we hope to illuminate.
No takes yet. Share an insight, caveat, or question.
Russell et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: